• +447723493307
  • info-ucg@utilitarianconferences.com
Login
WhatsApp

Track 5: Cardio-Oncology

Track 5: Cardio-Oncology

Sub Tracks: Cardiovascular Complications of Cancer Treatments, Cardiac Imaging in Cardio-Oncology, Biomarkers in Cardio-Oncology, Cardio-Protective Strategies,  Management of Specific Cardiovascular Complications, Cardiovascular Effects of Cancer Itself, Cardiovascular Health in Cancer Survivors, Special Populations in Cardio-Oncology, Role of Lifestyle and Rehabilitation, Advances in Cardio-Oncology Research, Multidisciplinary Approach in Cardio-Oncology,

What is cardio-oncology ?

cardio-oncology is an interdisciplinary medical field that focuses on the cardiovascular health of cancer patients and survivors. It examines the impact of cancer therapies (such as chemotherapy, radiation, and targeted therapies) on the heart and vascular system, with the goal of preventing, detecting, and managing cardiovascular complications related to cancer treatments.

1.     Cardiotoxicity of Cancer Treatments:

o    Chemotherapy: Certain chemotherapy drugs (e.g., anthracyclines, cyclophosphamide) can damage the heart muscle, leading to heart failure or arrhythmias.

o    Radiation: Chest radiation used to treat cancers like breast cancer or lymphoma can damage the heart, causing conditions such as coronary artery disease, heart valve problems, and pericardial disease.

o    Targeted Therapies: Drugs used in targeted cancer treatments (e.g., trastuzumab for HER2-positive breast cancer) can also affect the heart.

o    Immunotherapies: New treatments like immune checkpoint inhibitors (e.g., pembrolizumab) can cause inflammation of the heart (myocarditis) and other cardiovascular issues.

2.     Cardiovascular Risk Assessment:

o    Prior to starting cancer treatment, cardio-oncology specialists assess the cardiovascular health of cancer patients. They identify risks and decide on monitoring strategies to prevent or mitigate cardiotoxicity.

3.     Early Detection of Cardiotoxicity:

o    Monitoring heart function during and after cancer treatment is essential to detect early signs of heart damage. Techniques like echocardiography, MRI, and biomarkers (e.g., troponins, BNP) are commonly used to assess heart health.

4.     Management of Cardiovascular Complications:

o    If a patient develops heart problems as a result of cancer treatment, cardio-oncologists manage conditions such as heart failure, arrhythmias, hypertension, or coronary artery disease. Treatment may involve medications, lifestyle modifications, and sometimes adjustments in cancer therapy.

5.     Long-Term Surveillance:

o    Survivors of cancer may be at risk for developing cardiovascular disease years after their treatment. Regular follow-up care is necessary to monitor for late-onset cardiotoxicity and address any emerging heart problems.

6.     Cardiovascular Protection Strategies:

o    Cardio-oncology focuses on strategies to protect the heart during cancer treatment. This includes using cardioprotective drugs (e.g., dexrazoxane), lifestyle changes (e.g., exercise, diet), and optimizing cancer treatment regimens to minimize cardiovascular risks.

7.     Multidisciplinary Approach:

o    Cardio-oncology requires collaboration between oncologists, cardiologists, radiologists, and other healthcare providers. This multidisciplinary approach ensures that both cancer and heart health are carefully managed, often through integrated care teams and specialized cardio-oncology clinics.


Importance of Cardio-Oncology:

  • Growing Need: As cancer survival rates improve, more cancer patients and survivors are experiencing long-term cardiovascular complications due to their treatments.
  • Improved Outcomes: By addressing cardiovascular issues early, cardio-oncology improves patient outcomes, reduces treatment interruptions, and enhances quality of life.
  • Personalized Care: Cardio-oncology allows for the development of personalized care plans that balance effective cancer treatment with cardiovascular safety.